|
CTNND1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.47500037026316E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.39100000021253E-07 |
| Normal-vs-Stage2 |
2.21889999999503E-05 |
| Normal-vs-Stage3 |
2.39469999385733E-10 |
| Normal-vs-Stage4 |
1.15410014878137E-10 |
| Stage1-vs-Stage2 |
4.805200E-01 |
| Stage1-vs-Stage3 |
1.764300E-02 |
| Stage1-vs-Stage4 |
6.217900E-04 |
| Stage2-vs-Stage3 |
3.363400E-01 |
| Stage2-vs-Stage4 |
9.096200E-02 |
| Stage3-vs-Stage4 |
3.165600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.6886996769332E-10 |
| Normal-vs-AfricanAmerican |
2.353700E-02 |
| Normal-vs-Asian |
2.59999999996374E-06 |
| Caucasian-vs-AfricanAmerican |
1.530040E-01 |
| Caucasian-vs-Asian |
8.869200E-01 |
| AfricanAmerican-vs-Asian |
2.069200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.04970000259064E-08 |
| Normal-vs-Female |
1.20569998429687E-09 |
| Male-vs-Female |
7.795800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.19740000026347E-07 |
| Normal-vs-Age(41-60Yrs) |
1.76989999989274E-07 |
| Normal-vs-Age(61-80Yrs) |
2.69259947671685E-10 |
| Normal-vs-Age(81-100Yrs) |
1.124320E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.351400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.644070E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.227000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.247600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.485800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.770800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.317600E-03 |
| Classical-VS-Follicular |
2.336000E-01 |
| Classical-VS-Other |
8.562600E-01 |
| Classical-VS-Normal |
3.1859999971573E-08 |
| Tall-VS-Follicular |
1.794170E-01 |
| Tall-VS-Other |
5.424000E-01 |
| Tall-VS-Normal |
3.97059995993487E-09 |
| Follicular-VS-Other |
8.273600E-01 |
| Follicular-VS-Normal |
7.19680000038636E-07 |
| Other-VS-Normal |
4.214300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.41389996669517E-09 |
| Normal-vs-N1 |
5.78329999445515E-08 |
| N0-vs-N1 |
3.773600E-01 |
|
|
